We are live on
!
Find out more
HCM
Horton Capital Management Portfolio holdings
AUM
$44.9M
1-Year Est. Return
24.87%
This Fund
S&P 500
This Quarter
Est. Return
+23.14%
1 Year Est. Return
-24.87%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$133M
AUM Growth
+$27M
(+26%)
Cap. Flow
+$3.79M
Cap. Flow
% of AUM
2.85%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
1
Increased
3
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UroGen Pharma
URGN
|
+$3.22M |
| 2 |
MSON
Misonix Inc
MSON
|
+$672K |
| 3 |
SFE
Safeguard Scientifics, Inc.
SFE
|
+$589K |
| 4 |
KORU Medical Systems
KRMD
|
+$10.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Creative Realities
CREX
|
+$707K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 90.5% |
| 2 | Financials | 6.18% |
| 3 | Technology | 2.25% |
| 4 | Industrials | 1.05% |
Similar funds
NCP
CO
IP
HR
WLRC
HCIL
AC
BBCM
Horton Capital Management's Q2 2020 Portfolio in Review
As of Q2 2020, Horton Capital Management held 8 positions worth $133M, up 26% from $106M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Horton Capital Management's Q2 2020 filing shows 1 new, 3 increased and 1 reduced positions. Its largest new stake was Misonix Inc: 55,000 shares worth $746K. The largest sale was Creative Realities, an estimated $707K.
By sector, the portfolio is most concentrated in Healthcare at 90% of assets, down from 91% a quarter earlier, followed by Financials and Technology.
- Horton Capital Management's largest Q2 2020 buy was Misonix Inc: 55,000 shares worth $746K.
- Horton Capital Management added most to UroGen Pharma in Q2 2020, an estimated $3.22M increase.
- Horton Capital Management's biggest Q2 2020 reduction was Creative Realities, cutting an estimated $707K.
- Horton Capital Management's ten largest holdings make up 100% of its $133M portfolio in Q2 2020.
- Horton Capital Management opened 1 new position and closed 0 in Q2 2020.
- Horton Capital Management's portfolio value rose 26% quarter-over-quarter to $133M.
Based on Horton Capital Management's 13F filing for Q2 2020, filed 12 Aug 2020.